Phase 3 Study to Evaluate IOP Lowering Therapy in Open Angle Glaucoma and Ocular Hypertension C-02-41

Phase 3

Completed

• Conditions: Open-Angle Glaucoma; Ocular Hypertension

• Registration Number: NCT00047528
• Lead Sponsor: Alcon Research

Brief Summary

To compare intraocular pressure lowering effectiveness of a combination drug vs. two individual drugs dosed alone.

Detailed Description

Not available

Study Timeline

• Study Start: 2001-01
• Study First Submitted: 2002-10-08
• Study First Submitted QC: 2002-10-17
• Study First Posted: 2002-10-18
• Primary Completion: 2003-11
• Study Completion: 2003-11
• Status Verified: 2008-08
• Last Update Submitted: 2008-08-04
• Last Update Posted: 2008-08-05

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Trial Locations

Locations (1)

Clinical Trial Sites; 🇺🇸 Fort Worth, Texas, United States